Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
BMJ Clinical Evidence|February 25, 2016
Age-related macular degeneration: anti-vascular endothelial growth factor treatmentJennifer J ArnoldRetinal Cases & Brief Reports|November 13, 2014
Four-month back pain after verteporfin treatment: clinical case notesClare L Fraser, Jennifer J ArnoldTranslational Vision Science & Technology|November 7, 2024
Impairment of Neurovascular Function in Intermediate Age-Related Macular DegenerationBang Bui, Robyn H Guymer, Wilson Heriot, et al.BMC Ophthalmology|March 25, 2016
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID studyJennifer J Arnold, Caroline M Markey, Nicol P Kurstjens, et al.Ophthalmology|October 7, 2016
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational StudyMark C Gillies, Vuong Nguyen, Vincent Daien, et al.Clinical & Experimental Optometry|April 28, 2022
Effect of hydroxychloroquine or chloroquine and short wavelength light on in vivo retinal function and structure in mouse eyesWilson Heriot, Vickie Hy Wong, Zheng He, et al.The British Journal of Ophthalmology|August 26, 2021
Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX studySamantha Fraser-Bell, Hyong Kwon Kang, Paul Mitchell, et al.Clinical & Experimental Ophthalmology|May 29, 2020
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationShaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, et al.The British Journal of Ophthalmology|October 21, 2017
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studiesGiovanni Staurenghi, Nicolas Feltgen, Jennifer J Arnold, et al.Pageof 6